A.M. Schumann

602 total citations
15 papers, 442 citations indexed

About

A.M. Schumann is a scholar working on Cancer Research, Pharmacology and Molecular Biology. According to data from OpenAlex, A.M. Schumann has authored 15 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 7 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in A.M. Schumann's work include Carcinogens and Genotoxicity Assessment (11 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). A.M. Schumann is often cited by papers focused on Carcinogens and Genotoxicity Assessment (11 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). A.M. Schumann collaborates with scholars based in United States, India and France. A.M. Schumann's co-authors include P.G. Watanabe, Richard H. Reitz, T Fox, J.F. Quast, William T. Stott, J. Justin McCormick, Barry L. Yano, Vincent Maher, Matthew W. Himmelstein and James N. McDougal and has published in prestigious journals such as Toxicology and Applied Pharmacology, Regulatory Toxicology and Pharmacology and Toxicologic Pathology.

In The Last Decade

A.M. Schumann

14 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M. Schumann United States 9 260 146 121 110 68 15 442
Douglas Caudill United States 13 161 0.6× 132 0.9× 151 1.2× 166 1.5× 58 0.9× 19 529
E. Deml Germany 13 222 0.9× 182 1.2× 157 1.3× 168 1.5× 64 0.9× 29 531
Wang Rui-Sheng Japan 11 178 0.7× 90 0.6× 205 1.7× 124 1.1× 95 1.4× 14 441
V. Morrison United States 13 209 0.8× 224 1.5× 84 0.7× 169 1.5× 54 0.8× 20 520
Doris Oesterle Germany 14 250 1.0× 140 1.0× 73 0.6× 194 1.8× 80 1.2× 42 556
Mario Mazzullo Italy 13 273 1.1× 143 1.0× 56 0.5× 150 1.4× 39 0.6× 35 436
Gottfried Raab Germany 10 166 0.6× 134 0.9× 169 1.4× 121 1.1× 41 0.6× 22 365
Franz Kiefer Germany 12 231 0.9× 212 1.5× 182 1.5× 337 3.1× 102 1.5× 22 683
Shawn D. Seidel United States 10 135 0.5× 274 1.9× 73 0.6× 213 1.9× 46 0.7× 16 620
Vicki L. Burnett United States 10 165 0.6× 94 0.6× 218 1.8× 152 1.4× 112 1.6× 14 518

Countries citing papers authored by A.M. Schumann

Since Specialization
Citations

This map shows the geographic impact of A.M. Schumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Schumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Schumann more than expected).

Fields of papers citing papers by A.M. Schumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Schumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Schumann. The network helps show where A.M. Schumann may publish in the future.

Co-authorship network of co-authors of A.M. Schumann

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Schumann. A scholar is included among the top collaborators of A.M. Schumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Schumann. A.M. Schumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rouby, Nihal El, et al.. (2025). Multi‐Gene Pharmacogenomic Testing in a Community‐Based Setting Is Feasible and Reduces Total Healthcare Costs. Clinical and Translational Science. 18(12). e70418–e70418.
2.
Spencer, P.J., James W. Crissman, William T. Stott, et al.. (2002). Propylene Glycol Monomethyl Ether (PGME): Inhalation Toxicity and Carcinogenicity in Fischer 344 Rats and B6C3F1 Mice. Toxicologic Pathology. 30(5). 570–579. 21 indexed citations
3.
Reitz, Richard H., Michael L. Gargas, Alan L. Mendrala, & A.M. Schumann. (1996). In Vivoandin VitroStudies of Perchloroethylene Metabolism for Physiologically Based Pharmacokinetic Modeling in Rats, Mice, and Humans. Toxicology and Applied Pharmacology. 136(2). 289–306. 48 indexed citations
4.
Fox, T, A.M. Schumann, P.G. Watanabe, et al.. (1990). Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens.. PubMed. 50(13). 4014–9. 81 indexed citations
5.
Hanley, Thomas R., et al.. (1989). Metabolism and disposition of ethylene carbonate in male Fischer 344 rats. Toxicology and Applied Pharmacology. 100(1). 24–31. 3 indexed citations
6.
Reitz, Richard H., James N. McDougal, Matthew W. Himmelstein, R.J. Nolan, & A.M. Schumann. (1988). Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations. Toxicology and Applied Pharmacology. 95(2). 185–199. 67 indexed citations
7.
Watanabe, P.G., A.M. Schumann, & Richard H. Reitz. (1988). Toxicokinetics in the evaluation of toxicity data. Regulatory Toxicology and Pharmacology. 8(4). 408–413. 5 indexed citations
8.
Fox, T, A.M. Schumann, & P.G. Watanabe. (1987). Activation of a Cellular Proto-Oncogene in Spontaneous Liver Tumor Tissue of the B6C3F1 Mouse. Archives of toxicology. Supplement. 10. 217–227. 8 indexed citations
9.
Watanabe, P.G., T Fox, Richard H. Reitz, A.M. Schumann, & Melvin E. Andersen. (1987). RESEARCH STRATEGY IN INDUSTRIAL TOXICOLOGY. The Journal of Toxicological Sciences. 12(2). 223–233. 1 indexed citations
10.
Reitz, Richard H., A.M. Schumann, P.G. Watanabe, & P.J. Gehring. (1982). Genetic vs. Nongenetic Chemical Carcinogenesis and Risk Assessment. PubMed. 21. 425–438. 4 indexed citations
11.
Schumann, A.M., T Fox, & P.G. Watanabe. (1982). [14C]Methyl chloroform (1,1,1-trichloroethane): Pharmacokinetics in rats and mice following inhalation exposure. Toxicology and Applied Pharmacology. 62(3). 390–401. 32 indexed citations
12.
Schumann, A.M., T Fox, & P.G. Watanabe. (1982). A comparison of the fate of inhaled methyl chloroform (1,1,1-trichloroethane) following single or repeated exposure in rats and mice. Fundamental and Applied Toxicology. 2(1). 27–32. 17 indexed citations
13.
Stott, William T., Richard H. Reitz, A.M. Schumann, & P.G. Watanabe. (1981). Genetic and nongenetic events in neoplasia. Food and Cosmetics Toxicology. 19(5). 567–576. 58 indexed citations
14.
Schumann, A.M., J.F. Quast, & P.G. Watanabe. (1980). The pharmacokinetics and macromolecular interactions of perchloroethylene in mice and rats as related to oncogenicity. Toxicology and Applied Pharmacology. 55(2). 207–219. 85 indexed citations
15.
Reitz, Richard H., J.F. Quast, A.M. Schumann, P.G. Watanabe, & P.J. Gehring. (1980). Non-Linear Pharmacokinetic Parameters Need to be Considered in High Dose/Low Dose Extrapolation. Archives of toxicology. Supplement. 3. 79–94. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026